2m 2m 2m 2m 2m 2m 2m
Kura Oncology (KURA)
NASDAQ
$9.83-$0.06 (-0.56%)
Price as of Oct 22, 2026 7:30 PM EDT- $878.9MMarket Cap
- 6.47%1-Year Change
- BiotechnologyIndustry
Kura Oncology (KURA)
$9.83-$0.06 (-0.56%)
KURA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.88 | ||
Change | -$0.10 (-1.00%) | ||
Open | $10.04 | ||
High | $10.18 | ||
Low | $9.85 | ||
Previous Close | $9.98 | ||
Volume | 1,151,002 | ||
30-Day Average Volume | 1,734,491 | ||
1-Week Change | 2.81% | ||
1-Month Change | -14.83% | ||
1-Year Change | 6.47% | ||
3-Year Change | 19.47% | ||
5-Year Change | -43.48% | ||
Fundamentals | |||
Shares Outstanding | 89.0M | ||
Total Assets | $587.8M | ||
Market Cap | $878.9M | ||
Enterprise Value | $818.5M | ||
Period: QTR TTM FY | |||
Revenue | $9.1M | ||
Net Income | -$68.3M | ||
Free Cash Flow | -$63.2M | ||
EBIT | -$68.3M | ||
EBITDA | -$68.0M | ||
Net Working Capital | $441.2M | ||
EPS | -$0.77 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 90 | ||
P/B | 18 | ||
P/E | -13 | ||
PEG | -2 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue